Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021391 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Milica Zeković und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Be…. Hauptthemen laut MEDLINE: Lipid Metabolism, Prostatic Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science and Technological Development of the Republic of Serbia.
Abstract (Originalsprache)
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate mutational landscape and vast intra- and intertumor variability on both genetic and phenotypic levels. Prostate cancer (PCa) is the second most prevalent malignant disease among men worldwide. A single metabolic program cannot epitomize the perplexing reprogramming of tumor metabolism needed to sustain the stemness of neoplastic cells and their prominent energy-consuming functional properties, such as intensive proliferation, uncontrolled growth, migration, and invasion. In cancerous tissue, lipids provide the structural integrity of biological membranes, supply energy, influence the regulation of redox homeostasis, contribute to plasticity, angiogenesis and microenvironment reshaping, mediate the modulation of the inflammatory response, and operate as signaling messengers, i.e., lipid mediators affecting myriad processes relevant for the development of the neoplasia. Comprehensive elucidation of the lipid metabolism alterations in PCa, the underlying regulatory mechanisms, and their implications in tumorigenesis and the progression of the disease are gaining growing research interest in the contemporary urologic oncology. Delineation of the unique metabolic signature of the PCa featuring major aberrant pathways including de novo lipogenesis, lipid uptake, storage and compositional reprogramming may provide novel, exciting, and promising avenues for improving diagnosis, risk stratification, and clinical management of such a complex and heterogeneous pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
- Clinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Milica Zeković, Uros Bumbaširević
Förderung
- Ministry of Education, Science and Technological Development of the Republic of Serbia
Zitieren
APA
Zeković, M., Bumbaširević, U., Živković, M., & Pejčić, T. (2023). Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021391
Vancouver
Zeković M, Bumbaširević U, Živković M, Pejčić T. Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021391
BibTeX
@article{Zekovi2023,
author = {Zeković, Milica and Bumbaširević, Uros and Živković, Marko and Pejčić, Tomislav},
title = {Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021391}
}
EUVIMED